The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients With Malignant Melanoma: Preliminary Findings

Neuropsychopharmacology - United Kingdom
doi 10.1038/npp.2013.85
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Importance of the Immune System and Immunotherapeutic Options in Malignant Melanoma

Klinicka Onkologie
Oncology
2015English

Diagnostic Delay in Patients Diagnosed With Cutaneous Malignant Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Endoscopic Findings in a Patient With Primary Malignant Melanoma of the Esophagus: A Case Report

Advances in Digestive Medicine
2019English

The Impact of Anxiety on Social Decision-Making: Behavioral and Electrodermal Findings

Social Neuroscience
DevelopmentSocial PsychologyBehavioral Neuroscience
2013English

Evidence and Impact of Neutrophil Extracellular Traps in Malignant Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2019English

Immunotherapy-Induced Leukoderma From Treatment of Melanoma With IL-2: A Case Report and a Review of the Literature

Acta Dermato-Venereologica
DermatologyMedicine
2015English

Protein Expression Changes Induced in a Malignant Melanoma Cell Line by the Curcumin Analogue Compound D6

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Prognostic Impact of P62 Expression in Cutaneous Malignant Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy